Today, ACI, along with 75 organizations and activists, sent a letter to Congress opposing Medicare-for-All legislation that includes provisions for the government to set prescription prices. The letter is available online.
Senator and presidential-hopeful Elizabeth Warren (D-Ma) has made headlines in recent weeks by releasing the details of how she would fund her vision of Medicare-for-All. But far from the headlines, and hidden deep in her 9,000 word blueprint, lies her plan to put a stop to American medical innovation. By strong-arming innovators and removing all […]
Today, ACI joined twenty-two other nonprofits in support of legislation that would reduce the cost of medications by providing Medicare patients access to lower-cost generic drugs and biosimilars. The letter is available online.
Today, ACI released a coalition letter to Congress in opposition to creating an inflationary rebate penalty in Medicare Part D. You can download and print the letter here.
Cell and gene therapies have the potential to save lives and can offset significant direct and indirect costs to our healthcare system, thus saving taxpayers money in the long run, according to this broad coalition letter.
What if there was a way to simultaneously reduce the stunning levels of health care fraud in the United States while also combating the opioid crisis ravaging our communities? Well, there is. To read this op-ed, please visit the Morning Consult.
Replacing the current Medicare card with a high-tech “smart card” could help prevent billions of dollars in fraud while reducing medical errors and saving lives. To Read this op-ed, visit Real Clear Health.
Thinking of retiring in a few years? Beware of what is likely to come. Government has created a massive, new and costly benefit called the Affordable Care Act (ACA). At the same time, government has been burnishing existing programs to rapidly convert people into beneficiaries. Taxpayers will soon be hijacked to pay the unprecedented costs, […]
Some of the government decisions that push Americans toward the brink of sanity are in healthcare policies that can and should be reversed. With forethought and some political courage, better health policies can be adopted that allow consumers to make better arrangements and save substantially. The following opportunities call for smarter government policies – they […]
In November 2013, the FDA ordered a medical testing upstart named 23andMe to halt selling its $99 genetic testing service to consumers until it could prove the tests were reliable. By February 2015, 23andMe was vindicated and able to sell at least some testing. The FDA announced that it will allow patients to get partial […]